Recruiting
Periodic Continuous Glucose Monitoring in Patients With Type 2 Diabetes
The aim of this randomised controlled trial is to investigate the effectiveness of periodic CGM (continuous glucose monitoring) to support a person-centered approach versus self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes on glucose control and patient reported outcomes.
ClinicalTrials.gov IDNCT05633628
PhaseNA
Enrollment400
SponsorSophiahemmet University
Age18 Years
SexALL
Conditions studied
Type 2 Diabetes
About this study
The aim of this randomised controlled trial is to investigate the effectiveness of periodic CGM (continuous glucose monitoring) to support a person-centered approach versus self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes on glucose control and patient reported outcomes.
Interventions
- Behavioral: Periodic CGM group with data analysis report- Intervention group — The patients are also instructed to continue to perform SMBG by finger prick if they experience symptoms of hypo- or hyperglycemia. During visit 0 (baseline) the patients is also instructed about how they can log in to the National Diabetes Register (NDR) to access their own NDR's recorded data and use the diabetes questionnaire.
Primary outcomes
- HbA1c (change at week 16)
Eligibility information
Inclusion Criteria:
* Adults aged 18-80 years
* Type 2 diabetes with a duration of \> 6 months
* HbA1c 45-70 mmol/mol
* Have a smartphone
* Experience of self-monitoring of blood glucose prior to the study start
Exclusion Criteria:
* Prandial insulin
* Pregnancy or planning pregnancy during the study
* Breastfeeding
* Renal disease with estimated glomerular filtration rate (eGFR) \<45 mL/ min/1.73 m2
* Active malignancy or under investigation for malignancy
* Severe visual impairment
* Severe skin allergy that inhibits the use of a continuous glucose monitoring device
* Glucocorticoids (systemic)
* Planned or currently using weight reduction medications, programs, or surgery
* Cognitively or psychologically unable to participate and read instructions
* Enrolled in other clinical trials
* Eating disorders
Study locations
- Sophiahemmet University, Stockholm, Sweden
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-30.